¶ Precision NanoSystems
.png)
Precision NanoSystems Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was co-founded by Pieter Cullis, who also co-founded Acuitas Therapeutics.[1] His co-founders are Euan Ramsay and James Taylor.
The company develops genetic medicine-based therapies, including “self-assembling” molecules that carry drugs and gene therapies directly into the cells of the human body using DNA and RNA encapsulated in lipid nanoparticles.[2][3] It was launched with assistance from Genome British Columbia.[4]
¶ History
Precision NanoSystems was founded in 2010 by Pieter Cullis, Euan Ramsay and James Taylor.[1:1][5]
¶ COVID-19
The COVID-19 Vaccine Task Force considered a proposal from Precision NanoSystems on June 22, 2020.[6]
Representatives from Precision NanoSystems met with the Government of Canada's COVID-19 Joint Biomanufacturing Subcommittee on July 6 and 10, 2020, to discuss a "biomanufacturing project."[7]
On October 23, 2020, Canadian Prime Minister Justin Trudeau announced that he had awarded the company $18.2 million from the Government of Canada to develop an RNA vaccine for COVID-19.[8] The funding came from Innovation, Science and Economic Development Canada’s Strategic Innovation Fund (SIF), which focuses on supporting private sector-led vaccine and therapy clinical trials.
The company was acquired by Danaher on June 1, 2021.[5:1]
In July 2022, Replicate Bioscience issued a press release announcing a partnership with Precision NanoSystems to “accelerate the creation, scale-up, and delivery of self-replicating RNA (srRNA) therapies.”[9]
¶ Investors
Investors in Precision NanoSystems include:[10]
- 5AM Ventures
- Accel-Rx
- Northview LifeSciences
- Rising Tide
- Telegraph Hill Partners
¶ External links
Cullis, P. (2019, June 25). Innovation as a Driver for Personalized Medicine in British Columbia. Reboot Communications. https://web.archive.org/web/20210713174744/https://www.rebootcommunications.com/wp-content/uploads/2019/06/Cullis-Kelowna-June-2019.pdf ↩︎ ↩︎
Create Transformative Medicines. Precision NanoSystems. Retrieved March 8, 2022, from http://archive.today/2021.07.24-200212/https://www.precisionnanosystems.com/ ↩︎
Shore, R. (2016, February 25). Vancouver-Based Nanomedicine Startup Targets Genetic Solution to Diseases. Precision NanoSystems. http://archive.today/2022.03.09-051358/https://www.precisionnanosystems.com/news-room/detail/vancouver-based-nanomedicine-startup-targets-genetic-solution-diseases ↩︎
Annual Report 2020-2021. Genome BC. Retrieved April 18, 2022, from https://web.archive.org/web/20210703114654/https://www.genomebc.ca/wp-content/uploads/2021/06/GBC-5198-2020-21-AR-FINAL_WEB.pdf ↩︎
Precision NanoSystem - Crunchbase Company Profile & Funding. Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem ↩︎ ↩︎
COVID-19 Vaccine Task Force Registry of Interests. (2023, March 27). Innovation, Science and Economic Development Canada. http://archive.today/2023.07.09-180656/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-vaccine-task-force-registry-interests ↩︎
Innovation, Science and Economic Development Canada. (2022, July 7). COVID-19 Joint Biomanufacturing Subcommittee. Government of Canada. http://archive.today/2024.04.30-223848/https://ised-isde.canada.ca/site/biomanufacturing/en/covid-19-vaccine-task-force/covid-19-joint-biomanufacturing-subcommittee ↩︎
Precision NanoSystems. (2020, October 26). Prime Minister announces LSI spinoff to receive funding to develop an RNA Vaccine for COVID-19 | Life Sciences Institute. University of British Columbia. https://lsi.ubc.ca/2020/10/26/prime-minister-announces-lsi-spinoff-to-receive-funding-to-develop-rna-vaccine-for-covid-19/ ↩︎
Replicate Bioscience. (2022, July 26). Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines. Cision Newswire. https://web.archive.org/web/20230207015748/https://www.newswire.ca/news-releases/precision-nanosystems-and-replicate-bioscience-in-licensing-deal-to-scale-up-genomic-medicines-888682943.html ↩︎
Precision NanoSystem - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved February 7, 2023, from https://www.crunchbase.com/organization/precision-nanosystem/company_financials ↩︎